Akava Therapeutics Inc.

New Filing

CIK: 0001966649·Pharmaceuticals·DELAWARE·Filed: Mar 3, 2023

Total Offering

$10,000,000

Amount Sold

$0

Investors

0

First Sale

N/A

Offering Details

Type: Option to Acquire
Exemptions: Rule 506(c)
Entity Type: Corporation
Year Incorporated: 2019
Non-Accredited Investors: No

Related Persons

Name	Role
Philip Silverman	Related Person
Richard Silverman	Related Person
Brendan MacMillan	Related Person

Company

Akava Therapeutics Inc.

755 SHERIDAN ROAD

WINNETKA, IL, 60093

(847) 494-7434

SEC Filing

0001966649-23-000001

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.